MW
Marco Weinberg
Senior Vice President, Head Of Research at Recode Therapeutics
View Marco's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Senior Vice President, Head Of Research
Aug 2023 - Present · 1 years and 4 months
Vice President, R&D Gene Editing
Feb 2021 - Aug 2023 · 2 years and 6 months
Director, Gene Therapy Research
Jan 2020 - Feb 2021 · 1 years and 1 months
Company Details
11-50 Employees
ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver.
Website
Year Founded
2015
Social Media
LinkedinTwitter
Industry
Biotechnology Research
HQ Location
Menlo Park, California & Dallas, Texas, US
Keywords
RNA TherapiesGenetic MedicinesNon-Viral Lipid NanoparticlesGenetic Respiratory DiseaseCystic FibrosisPrimary Ciliary DyskinesiBiotechnology
Contact Details
- Email AddressM**@recodetx.comReveal Email
- Phone Number(xxx)xxx-xxxxReveal Phone
Find verified contacts of Marco Weinberg in seconds from 700M people profiles. Start now!
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.